INFLUENCE OF DONOR AND HISTOCOMPATIBILITY FACTORS ON CORNEAL GRAFT OUTCOME

被引:64
作者
VAIL, A
GORE, SM
BRADLEY, BA
EASTY, DL
ROGERS, CA
ARMITAGE, WJ
机构
[1] UNIV FORVIE SITE, INST PUBL HLTH, MRC, BIOSTAT UNIT, CAMBRIDGE CB2 2SR, ENGLAND
[2] UNIV BRISTOL, BRISTOL EYE HOSP, DEPT OPHTHALMOL, BRISTOL BS1 2LX, AVON, ENGLAND
[3] UNITED KINGDOM TRANSPLANT SUPPORT SERV AUTHOR, BRISTOL BS12 6RR, AVON, ENGLAND
关键词
D O I
10.1097/00007890-199412150-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Corneal Transplant Follow-up Study has followed 2311 penetrating keratoplasties for up to 450 days after transplant, A total of 207 failures were observed, including 65 classical rejections and 35 endothelial decompensations, At 12 months, graft survival was 89%, and survival free from rejection was 87%. For surviving grafts, risk of failure reduced from 4.8% in the first 75 days and stabilized after 5 months at 1.2% in each 75-day interval. Risk of rejection initially followed a similar pattern, but then increased after 12 months. Multifactorial analyses accounted for differences in recipient characteristics and interrelationships of donor factors. Donor age, sex, cause of death, and method of corneal storage were not found to influence significantly either time to graft failure or time to first rejection. Grafts in prospectively tissue-typed donor-recipient pairs were generally considered before surgery to be at increased risk of either graft failure or rejection. With due allowance, increasing risk of rejection was associated with increasing numbers of mismatches at HLA-A and HLA-B broad antigens. The opposite was true at HLA-DR broad antigens, where increased risk of rejection was observed with no mismatches.
引用
收藏
页码:1210 / 1216
页数:7
相关论文
共 29 条
  • [1] [Anonymous], 1992, Arch Ophthalmol, V110, P1392
  • [2] SUPPLY OF CORNEAL TISSUE IN THE UNITED-KINGDOM
    ARMITAGE, WJ
    MOSS, SJ
    EASTY, DL
    BRADLEY, BA
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (11) : 685 - 687
  • [3] Baggesen K, 1990, Clin Transpl, P197
  • [4] BATCHELOR JR, 1976, LANCET, V1, P551
  • [5] BOISJOLY HM, 1986, OPHTHALMOLOGY, V93, P1290
  • [6] CASEY TA, 24 ACT INT C OPHTH P
  • [7] CHIPMAN ML, 1990, ACTA OPHTHALMOL, V68, P537
  • [8] COX DR, 1972, J R STAT SOC B, V34, P187
  • [9] ANALYZING TRANSPLANT SURVIVAL-DATA
    GILKS, WR
    GORE, SM
    BRADLEY, BA
    [J]. TRANSPLANTATION, 1986, 42 (01) : 46 - 49
  • [10] HOLLAND EJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P542